Market Cap : 7.61 B | Enterprise Value : 6.56 B | PE Ratio : | PB Ratio : 8.97 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Ionis Pharmaceuticals's sale of investment for the three months ended in Dec. 2020 was $388.5 Mil. It means Ionis Pharmaceuticals gained $388.5 Mil from selling investments. Ionis Pharmaceuticals's sale of investment for the trailing twelve months (TTM) ended in Dec. 2020 was $1,885.9 Mil.
Compared with last quarter ($515.3 Mil in Sep. 2020 ), Ionis Pharmaceuticals gained less money from selling investments in Dec. 2020 ($388.5 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Sale of Investments represents cash inflow on the sale of investments in securities.
Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2020 was 459.352 (Mar. 2020 ) + 522.821 (Jun. 2020 ) + 515.26 (Sep. 2020 ) + 388.502 (Dec. 2020 ) = $1,885.9 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline